[1]
X. Zhang, “GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells: Liraglutide inhibits thyroid cancer cells”, Cell Mol Biol (Noisy-le-grand), vol. 69, no. 14, pp. 221–225, Dec. 2023.